aspirin has been researched along with Shock, Cardiogenic in 26 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "AIMS Immediate treatment with a loading dose of clopidogrel at diagnosis of ST-segment elevation myocardial infarction (STEMI) is recommended by ESC/AHA/ACC guidelines in patients eligible for primary percutaneous coronary intervention (PCI)." | 7.77 | Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. ( Erlinge, D; James, S; Koul, S; Lagerqvist, B; Scherstén, F; Smith, JG, 2011) |
| "Dual antiplatelet therapy with aspirin and P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction (STEMI) has been shown to be associated with better outcomes." | 5.41 | Effectiveness and Safety of P2Y12 Inhibitor Pretreatment for Primary PCI in STEMI: Systematic Review and Meta-analysis. ( Aguiar, C; Albuquerque, F; Almeida, M; Ferreira, J; Gomes, DA; Mendes, M; Presume, J; Uva, MS, 2023) |
| "AIMS Immediate treatment with a loading dose of clopidogrel at diagnosis of ST-segment elevation myocardial infarction (STEMI) is recommended by ESC/AHA/ACC guidelines in patients eligible for primary percutaneous coronary intervention (PCI)." | 3.77 | Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. ( Erlinge, D; James, S; Koul, S; Lagerqvist, B; Scherstén, F; Smith, JG, 2011) |
| "To evaluate the impact of introducing thrombolytic and aspirin therapy into the management policy of a coronary care unit, with particular reference to its effects on the hospital course of nonselected patients with acute myocardial infarction." | 3.68 | Clinical impact of introducing thrombolytic and aspirin therapy into the management policy of a coronary care unit. ( Ranjadayalan, K; Timmis, AD; Umachandran, V, 1992) |
| "Mortality in patients with STEMI-associated cardiogenic shock (CS) is increasing." | 1.56 | Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock. ( Ellis, SG; Huded, CP; Kapadia, SR; Khot, UN; Krishnaswamy, A; Krittanawong, C; Kumar, A; Lincoff, AM; Menon, V; Reed, GW; Young, LD; Zhou, L, 2020) |
| "A retrospective analysis of STEMI patients from 18 hospitals across Malaysia contributing to the Malaysian National Cardiovascular Database-acute coronary syndrome) registry (NCVD-ACS) year 2006-2013." | 1.51 | In-hospital mortality of cardiogenic shock complicating ST-elevation myocardial infarction in Malaysia: a retrospective analysis of the Malaysian National Cardiovascular Database (NCVD) registry. ( Hadi, MF; Hafidz, MI; Ismail, MD; Venkatason, P; Wan Ahmad, WA; Zubairi, YZ; Zuhdi, ASM, 2019) |
| "Cardiogenic shock was present in 12 (11%) patients and in-hospital mortality was 6." | 1.38 | The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI. ( Buffon, A; Burzotta, F; Crea, F; De Caterina, AR; Leone, AM; Mazzari, MA; Mongiardo, R; Niccoli, G; Porto, I; Rebuzzi, AG; Sgueglia, GA; Trani, C, 2012) |
| "Stent thrombosis is not unusual in a post-operative setting." | 1.38 | Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis. ( Agnani, S; Akkus, NI; Rajpal, S, 2012) |
| "Age and left bundle branch block were strong negative predictors for early reperfusion therapy in patients with prior antithrombotic treatment." | 1.35 | Impact of chronic antithrombotic therapy on hospital course of patients with acute myocardial infarction. ( Bauer, T; Bestehorn, K; Gitt, A; Jünger, C; Koeth, O; Senges, J; Towae, F; Zahn, R; Zeymer, U, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 10 (38.46) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Presume, J | 1 |
| Gomes, DA | 1 |
| Ferreira, J | 1 |
| Albuquerque, F | 1 |
| Almeida, M | 1 |
| Uva, MS | 1 |
| Aguiar, C | 1 |
| Mendes, M | 1 |
| Puram, RV | 1 |
| Erdil, RM | 1 |
| Weber, BN | 1 |
| Knelson, EH | 1 |
| Van Beuningen, AM | 1 |
| Wallwork, R | 1 |
| Gilyard, SN | 1 |
| Curtis, BR | 1 |
| Ranganathan, R | 1 |
| Leaf, RK | 1 |
| Malhotra, R | 1 |
| Kumar, A | 1 |
| Huded, CP | 1 |
| Zhou, L | 1 |
| Krittanawong, C | 1 |
| Young, LD | 1 |
| Krishnaswamy, A | 1 |
| Menon, V | 1 |
| Lincoff, AM | 1 |
| Ellis, SG | 1 |
| Reed, GW | 1 |
| Kapadia, SR | 1 |
| Khot, UN | 1 |
| De Rosa, G | 1 |
| Andreozzi, L | 1 |
| Piastra, M | 1 |
| Castelli, B | 1 |
| Rigante, D | 1 |
| Venkatason, P | 1 |
| Zubairi, YZ | 1 |
| Wan Ahmad, WA | 1 |
| Hafidz, MI | 1 |
| Ismail, MD | 1 |
| Hadi, MF | 1 |
| Zuhdi, ASM | 1 |
| Aslam, R | 1 |
| Ducrocq, N | 1 |
| Thivilier, C | 1 |
| Perez, P | 1 |
| Gerard, A | 1 |
| Kimmoun, A | 1 |
| Levy, B | 1 |
| Weeks, PA | 1 |
| Sieg, A | 1 |
| Paruthi, C | 1 |
| Rajapreyar, I | 1 |
| Radovanovic, D | 1 |
| Maurer, L | 1 |
| Bertel, O | 1 |
| Witassek, F | 1 |
| Urban, P | 2 |
| Stauffer, JC | 1 |
| Pedrazzini, G | 1 |
| Erne, P | 1 |
| Gogorishvili, I | 1 |
| Archvadze, A | 1 |
| Kipiani, V | 1 |
| Kipshidze, N | 1 |
| Said, SM | 1 |
| Albouaini, K | 1 |
| Herold, J | 1 |
| Hahn, J | 1 |
| Brucks, S | 1 |
| Schmidt, H | 1 |
| Schmeisser, A | 1 |
| Prondzinsky, R | 1 |
| Braun-Dullaeus, RC | 1 |
| Bauer, T | 1 |
| Gitt, A | 1 |
| Zahn, R | 1 |
| Jünger, C | 1 |
| Koeth, O | 1 |
| Towae, F | 1 |
| Bestehorn, K | 1 |
| Senges, J | 1 |
| Zeymer, U | 1 |
| Ponikowski, P | 1 |
| Ronco, C | 1 |
| Anker, SD | 1 |
| Koul, S | 1 |
| Smith, JG | 1 |
| Scherstén, F | 1 |
| James, S | 1 |
| Lagerqvist, B | 1 |
| Erlinge, D | 1 |
| Awad, HH | 1 |
| Zubaid, M | 1 |
| Alsheikh-Ali, AA | 1 |
| Al Suwaidi, J | 1 |
| Anderson, FA | 1 |
| Gore, JM | 1 |
| Goldberg, RJ | 1 |
| Leone, AM | 1 |
| Sgueglia, GA | 1 |
| Porto, I | 1 |
| Niccoli, G | 1 |
| Burzotta, F | 1 |
| Trani, C | 1 |
| De Caterina, AR | 1 |
| Buffon, A | 1 |
| Mazzari, MA | 1 |
| Mongiardo, R | 1 |
| Rebuzzi, AG | 1 |
| Crea, F | 1 |
| Akkus, NI | 1 |
| Rajpal, S | 1 |
| Agnani, S | 1 |
| Steg, PG | 2 |
| Bonnefoy, E | 1 |
| Chabaud, S | 1 |
| Lapostolle, F | 1 |
| Dubien, PY | 1 |
| Cristofini, P | 1 |
| Leizorovicz, A | 1 |
| Touboul, P | 1 |
| Danchin, N | 1 |
| De Benedetti, E | 1 |
| Katayama, T | 1 |
| Nakashima, H | 1 |
| Takagi, C | 1 |
| Honda, Y | 1 |
| Suzuki, S | 1 |
| Yano, K | 1 |
| Lemaitre, F | 1 |
| Close, L | 1 |
| Plein, D | 1 |
| Silance, PG | 1 |
| Vandenbossche, JL | 1 |
| Tatu-Chiţoiu, G | 1 |
| Teodorescu, C | 1 |
| Dan, M | 1 |
| Guran, M | 1 |
| Căpraru, P | 1 |
| Istrăţescu, O | 1 |
| Tatu-Chiţoiu, A | 1 |
| Bumbu, A | 1 |
| Chioncel, V | 1 |
| Arvanitopol, S | 1 |
| Dorobanţu, M | 1 |
| Himbert, D | 1 |
| Karrillon, GJ | 1 |
| Hvass, U | 1 |
| Juliard, JM | 1 |
| Aumont, MC | 1 |
| Gourgon, R | 1 |
| Görge, G | 1 |
| Haude, M | 1 |
| von Birgelen, C | 1 |
| Caspari, G | 1 |
| Erbel, R | 1 |
| Brodie, BR | 1 |
| Stuckey, TD | 1 |
| Hansen, C | 1 |
| Muncy, D | 1 |
| Barbash, IM | 1 |
| Battler, A | 1 |
| Behar, S | 1 |
| Boyko, V | 1 |
| Gottlieb, S | 1 |
| Hasdai, D | 1 |
| Leor, J | 1 |
| Ranjadayalan, K | 1 |
| Umachandran, V | 1 |
| Timmis, AD | 1 |
6 reviews available for aspirin and Shock, Cardiogenic
| Article | Year |
|---|---|
Effectiveness and Safety of P2Y12 Inhibitor Pretreatment for Primary PCI in STEMI: Systematic Review and Meta-analysis.
Topics: Aspirin; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inh | 2023 |
Antiplatelet Therapy Considerations in Ischemic Cardiogenic Shock: Implications of Metabolic Bioactivation.
Topics: Acute Coronary Syndrome; Aspirin; Drug Therapy, Combination; Humans; Myocardial Infarction; Myocardi | 2015 |
[Takotsubo syndrome from original description up to now].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; A | 2009 |
Acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitor | 2003 |
[Acute myocarditis: from chest pain to cardiogenic shock].
Topics: Acute Disease; Adult; Aged; Aspirin; Biopsy; Cardiotonic Agents; Chest Pain; Clinical Enzyme Tests; | 2005 |
[Reperfusion therapy in acute myocardial infarct].
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Heparin; Humans; Myocardial Infarction; Myocardial Re | 1995 |
1 trial available for aspirin and Shock, Cardiogenic
| Article | Year |
|---|---|
Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Ambulances; Angioplasty, Balloon, Coronary; Aspirin; Emergency Medic | 2003 |
19 other studies available for aspirin and Shock, Cardiogenic
| Article | Year |
|---|---|
Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies.
Topics: Antigens, Human Platelet; Arginine; Aspirin; Autoantibodies; Combined Modality Therapy; Coronary Thr | 2020 |
Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock.
Topics: Aged; Anticoagulants; Aspirin; Checklist; Clinical Protocols; Disease Management; Emergency Service, | 2020 |
Acute myocarditis as a revealing clue of complete Kawasaki disease.
Topics: Acute Disease; Aspirin; Child, Preschool; Dipyridamole; Drug Substitution; Female; Humans; Immunoglo | 2018 |
In-hospital mortality of cardiogenic shock complicating ST-elevation myocardial infarction in Malaysia: a retrospective analysis of the Malaysian National Cardiovascular Database (NCVD) registry.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Databases, Factual; Female; Hospital Mortal | 2019 |
Critical illness-related corticosteroid insufficiency in cardiogenic shock.
Topics: Adrenal Insufficiency; Adrenergic alpha-Agonists; Adult; Anti-Inflammatory Agents; Antihypertensive | 2013 |
Treatment and outcomes of patients with recurrent myocardial infarction: A prospective observational cohort study.
Topics: Age Factors; Aged; Aspirin; Cohort Studies; Comorbidity; Drug Utilization; Female; Guideline Adheren | 2016 |
Treatment of patients with cardiogenic shock in the setting of acute myocardial infarction. Case reports.
Topics: Aged; Angioplasty, Balloon; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carbazoles; Carvedilol | 2008 |
Impact of chronic antithrombotic therapy on hospital course of patients with acute myocardial infarction.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Bundle-Branch Block; Coumarins; Diabetes Mellitus; Femal | 2009 |
Cardiorenal syndromes--recommendations from clinical practice guidelines: the cardiologist's view.
Topics: Acute Disease; Acute Kidney Injury; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhib | 2010 |
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Female; Graft Occlusion, Vascular; Hemor | 2011 |
Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Aspiri | 2011 |
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI.
Topics: Aged; Aspirin; Chi-Square Distribution; Chromium Alloys; Clopidogrel; Coated Materials, Biocompatibl | 2012 |
Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Heparin; Humans; Intra-Aortic | 2012 |
Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock.
Topics: Angioplasty, Balloon; Aspirin; C-Reactive Protein; Cholesterol; Electrocardiography; Hormones; Human | 2005 |
Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Female | 2004 |
[Incidence and prognosis of early primary cardiogenic shock in myocardial infarction].
Topics: Aged; Aged, 80 and over; Angioplasty; Aspirin; Emergencies; Female; Heparin; Humans; Male; Middle Ag | 1994 |
Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Coronary Angiography; Fema | 2000 |
Aspirin and percutaneous coronary angioplasty are associated with a decline in mortality from cardiogenic shock. Results from a national Israeli survey, 1992--1998.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Coronary Angiography; Female; Health | 2001 |
Clinical impact of introducing thrombolytic and aspirin therapy into the management policy of a coronary care unit.
Topics: Age Factors; Aged; Aspirin; Coronary Care Units; Diuretics; Drug Therapy, Combination; Female; Hospi | 1992 |